Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2016 08:48 ET | Source: Alcobra Ltd.

Update from Alcobra on Recent FDA Communications

TEL AVIV, Israel, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
September 28, 2016 20:01 ET | Source: Alcobra Ltd.

Alcobra Announces IND Clinical Hold Affecting the MDX Phase III MEASURE Study

TEL AVIV, Israel, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
August 30, 2016 07:00 ET | Source: Alcobra Ltd.

Alcobra Announces Second Quarter 2016 Financial Results and Provides Corporate Update

TEL AVIV, Israel, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
August 15, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30

Tel Aviv, Israel, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
July 19, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Granted European Orphan Drug Designation for Metadoxine in Fragile X Syndrome

TEL AVIV, Israel, July 19, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
July 05, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference

TEL AVIV, Israel, July 05, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
June 01, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Participate in Upcoming Investment Conferences

TEL AVIV, Israel, June 01, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to treat patients with cognitive...
May 16, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update

Conference Call & Webcast May 16th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, May 16, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
May 04, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Release First Quarter Financial Results and Host Corporate Update Conference Call & Webcast on May 16

TEL AVIV, Israel, May 04, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
March 01, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present at Upcoming Investment Conferences

TEL AVIV, Israel, March 01, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right